Please use this identifier to cite or link to this item:

Trioxane derivatives

Authors Haynes, Richard K. HKUST affiliated (currently or previously)
Chan, Ho Wai HKUST affiliated (currently or previously)
Lam, Wai-Lun
Tsang, Hing Wo HKUST affiliated (currently or previously)
Hsiao, W. L. Wendy
Lerchen, Hans-Georg
Baumgarten, Jörg
Issue Date 2003-11-18
Source US Patent , 6,649,647 B1, 2003
Summary New methods for preparing analogues of qinghaosu (QHS, or artemisinin) and synthetic trioxane derivatives are developed. These new derivatives which have attached DNA-ligating groups are capable of aligning the trioxane nucleus proximate to specified base sequences in DNA. Despite the idea of combining DNA-binding and other ligands to pharmacophorea is not new, these derivatives synthesized are of new chemical entities. They were also tested for cytotoxicity and neurotoxity and screened against tumour cell lines. Results are very positive and some of the compounds are found to be active. The invention has the potential of providing a new array of drugs based on the trioxane pharmacophore. They can be developed into antitumour agents which act by selective destruction of DNA in tumour cells. Other potential applications include candidates for development into antineoplastic drugs. Currently, there are no examples of specific compounds of this kind reported in any literature.
Language English
Format Patent
Access View details of TTC.PA.070 via HKUST Technology Transfer Center
Files in this item:
File Description Size Format
US6649647TTC.PA.0070_20040205.pdf 2842318 B Adobe PDF